COLELLA SAMUEL D 4

Accession 0001209191-21-043553

CIK 0001419600other

View on SEC.gov Company Profile

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 6:32 PM ET

Size

15.9 KB

Accession

0001209191-21-043553

Insider Transaction Report

Form 4

Period: 2021-06-24

Flexion Therapeutics IncFLXN

COLELLA SAMUEL D

Director10% Owner

Transactions

Award
Common Stock
2021-06-24+4,500→ 11,198 total
Award
Stock option (right to buy)
2021-06-24+7,000→ 7,000 total
Exercise: $9.22Exp: 2031-06-23→ Common Stock (7,000 underlying)

Holdings

Common Stock
(indirect: By Trust)
1,000
Common Stock
(indirect: By Trust)
69,837
Common Stock
(indirect: By Versant Venture Capital III L.P.)
994,129
Common Stock
(indirect: By Versant Side Fund III)
5,871
Common Stock
(indirect: By LLC)
388,683
Common Stock
(indirect: By Colella Partners)
943
Common Stock
(indirect: By Colella Partners II)
19,653
Common Stock
(indirect: By Spouse)
250
Common Stock
(indirect: By Trust)
5,000

Footnotes (10)

[F1]Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan.
[F10]The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant.
[F2]Reflects the transfer of 1,000 shares to The Samuel Colella Trust.
[F3]The shares are held by the Colella Family Trust UTA Dtd. 9/21/92 ("Colella Trust"). The Reporting Person is a trustee and beneficiary of the Colella Trust.
[F4]The shares are held by the Colella Family Exempt Marital Deduction Trust Dated 9/21/1992 ("Colella Exempt Trust"). The Reporting Person is a trustee and beneficiary of the Colella Exempt Trust.
[F5]The shares are held by Versant Venture Capital III, L.P. ("VVC III"). The Reporting Person is a managing member of Versant Ventures III, LLC ("VV III"), the sole general partner of VVC III and shares voting and dispositive power over the shares held by VVC III; however, he disclaims beneficial ownership of the shares held by such entity except to the extent of his pecuniary interests therein.
[F6]The shares are held by Versant Side Fund III, L.P. ("Side Fund III"). The Reporting Person is a managing member of VV III, the sole general partner of Side Fund III and shares voting and dispositive power over the shares held by Side Fund III; however, he disclaims beneficial ownership of the shares held by such entity except to the extent of his pecuniary interests therein.
[F7]The shares are held by Versant Development Fund III, LLC ("Development III"). The Reporting Person is a managing member of VV III, a majority member of Development III and shares voting and dispositive power over the shares held by Development III; however, he disclaims beneficial ownership of the shares held by such entity except to the extent of his pecuniary interests therein.
[F8]Shares held by Colella Partners. The Reporting Person is the general partner of Colella Partners.
[F9]Shares held by Colella Partners II. The Reporting Person is the general partner of Colella Partners II.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Flexion Therapeutics Inc

CIK 0001419600

→

Entity typeother

Related Parties

filerCIK 0001201580

Filing Metadata

Form type: 4
Filed: Jun 27, 8:00 PM ET
Accepted: Jun 28, 6:32 PM ET
Size: 15.9 KB

View on SEC.gov